Cargando…
3-Dimensional micropillar drug screening identifies FGFR2-IIIC overexpression as a potential target in metastatic giant cell tumor
We established two patient derived tumor cells (PDCs) from right and left pulmonary metastatic lesions respectively of a patient with giant cell tumor. At that time, patient-derived tumor cells from right and left surgical specimens were collected and cultured. High-throughput screening (HTS) for 24...
Autores principales: | Kim, Seung Tae, Kim, Jusun, Shin, Sumin, Kim, Sun Young, Lee, Dongwoo, Ku, Bosung, Shin, Yong Sung, Kim, Jhingook, Lee, Jeeyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482670/ https://www.ncbi.nlm.nih.gov/pubmed/28445128 http://dx.doi.org/10.18632/oncotarget.16883 |
Ejemplares similares
-
Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion
por: Kim, Sun Young, et al.
Publicado: (2017) -
Systematic Evaluation of Gastric Tumor Cell Index and Two-Drug Combination Therapy via 3-Dimensional High-Throughput Drug Screening
por: Lim, Sung Hee, et al.
Publicado: (2019) -
Incidence of FGFR2 Amplification and FGFR2 Fusion in Patients with Metastatic Cancer Using Clinical Sequencing
por: Hyung, Sujin, et al.
Publicado: (2022) -
BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression
por: Kim, Se Hyun, et al.
Publicado: (2018) -
Thoracoscopic Removal of Ectopic Mediastinal Parathyroid Adenoma
por: Kim, Young Su, et al.
Publicado: (2014)